Educational information, not medical advice — ask your doctor or midwife.
Track Arjuna with reminders and record whether it helped, in the app.
Arjuna comes from the bark of the Terminalia arjuna tree, native to the Indian subcontinent and revered in Ayurveda as one of its most important heart medicines. Ancient Ayurvedic physicians like Vagbhata and Charaka documented its use for heart disease over two millennia ago. Today it is studied in modern cardiology research and used widely across South Asia as both a daily tonic and a therapeutic supplement.
Arjuna works through several pathways: its key compounds strengthen the heart muscle's pumping ability, help widen blood vessels to reduce the pressure the heart works against, and act as antioxidants that protect heart tissue from damage. It also appears to gently lower blood pressure and reduce LDL cholesterol, making it useful for overall cardiovascular health rather than just one symptom.
The traditional Ayurvedic preparation is Arjuna Ksheerapaka — bark powder simmered in milk, which is thought to improve absorption of its fat-soluble compounds. Modern forms include capsules and tablets (typically 500–1000 mg of bark powder) and standardized extracts. Clinical studies have used both the raw powder form and proprietary extracts. Most people find capsules most convenient; the traditional milk decoction is a gentler daily option.
Arjuna has one of the oldest documented uses in cardiac medicine of any plant in the world. Named after the warrior hero Arjuna in Hindu mythology — symbolizing strength and valor — it was described in the Ashtanga Hridayam and Sushruta Samhita for treating 'hrit shoola' (heart pain) and weak heart. It remained a cornerstone of Ayurvedic cardiac care for centuries and entered modern clinical investigation in India in the 1980s–90s, gaining international interest as heart failure research grew.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.